the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma
Official Title A Phase 1/2 Trial of X4P-001 as Single Agent and in Combination With Axitinib in Patients With Advanced Renal Cell Carcinoma
Principal Investigator Stadler, Walter
Brief Summary The purpose of the study is to test different doses of X4P-001 given alone and in combination with axitinib in patients diagnosed with advanced renal cell carcinoma. The goals of the study are to determine the safety and tolerability of X4P-001, as well as the potential effect it may have on the body and the cancer tumor.
Gender All
Ages 18 Years
Enrollment 83
Accepts Healthy Volunteers No
Lead Sponsor X4 PharmaceuticalsIndustry
Collaborator
Study Design
Study Phase Phase 1/Phase 2
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Clear Cell Renal Cell Carcinoma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI